Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring
- PMID: 17521525
Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring
Similar articles
-
[Diabetic nephropathy].Dtsch Med Wochenschr. 2007 May 11;132(19):1039-42. doi: 10.1055/s-2007-979378. Dtsch Med Wochenschr. 2007. PMID: 17476634 Review. German. No abstract available.
-
[The kidneys and diabetes].Dtsch Med Wochenschr. 2008 Sep;133(37):1848-52. doi: 10.1055/s-0028-1082808. Epub 2008 Sep 3. Dtsch Med Wochenschr. 2008. PMID: 18770486 Review. German. No abstract available.
-
[Prediction, screening and treatment of renal complications of diabetes].Rev Prat. 2001 Oct 15;51(16):1769-75. Rev Prat. 2001. PMID: 11795120 French.
-
[Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].An Med Interna. 1998 Nov;15(11):567-71. An Med Interna. 1998. PMID: 9882851 Review. Spanish. No abstract available.
-
[Control of arterial pressure in diabetic nephropathy].Nefrologia. 2001 May-Jun;21(3):240-5. Nefrologia. 2001. PMID: 11471304 Review. Spanish. No abstract available.
Cited by
-
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.Diabetes Care. 2009 Oct;32(10):1873-9. doi: 10.2337/dc09-0168. Epub 2009 Jul 8. Diabetes Care. 2009. PMID: 19587362 Free PMC article. Clinical Trial.
-
Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.Pediatr Nephrol. 2010 Jan;25(1):27-35. doi: 10.1007/s00467-009-1251-5. Epub 2009 Jul 15. Pediatr Nephrol. 2010. PMID: 19603189 Review.
-
The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.Diab Vasc Dis Res. 2014 Sep;11(5):306-23. doi: 10.1177/1479164114542802. Diab Vasc Dis Res. 2014. PMID: 25116004 Free PMC article. Review.
-
Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Crit Rev Clin Lab Sci. 2009;46(3):129-52. doi: 10.1080/10408360902805261. Crit Rev Clin Lab Sci. 2009. PMID: 19404829 Free PMC article. Review.
-
Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis.Diabetes Ther. 2018 Jun;9(3):1021-1036. doi: 10.1007/s13300-018-0410-8. Epub 2018 Mar 29. Diabetes Ther. 2018. PMID: 29600504 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical